218952-60-4

Basic information

• Product Name: 1,2,4-Piperazinetricarboxylic acid, 2-(2-pyridinylmethyl)-, 4-(1,1-dimethylethyl) 2-methyl 1-(phenylmethyl) ester
• CAS NO: 218952-60-4
• Molecular Formula: C25H31N3O6
• Molecular Weight: 469.538
• Mol File: 218952-60-4.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1,2,4-Piperazinetricarboxylic acid, 2-(2-pyridinylmethyl)-, 4-(1,1-dimethylethyl) 2-methyl 1-(phenylmethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,4-Piperazinetricarboxylic acid, 2-(2-pyridinylmethyl)-, 4-(1,1-dimethylethyl) 2-methyl 1-(phenylmethyl) ester(218952-60-4)
• EPA Substance Registry System: 1,2,4-Piperazinetricarboxylic acid, 2-(2-pyridinylmethyl)-, 4-(1,1-dimethylethyl) 2-methyl 1-(phenylmethyl) ester(218952-60-4)

Safety Data

• Hazardous Substances Data: 218952-60-4(Hazardous Substances Data)

Upstream product

• 126937-42-6 piperazine-1,2,4-tricarboxylic acid 1-benzyl ester 4-tert-butyl ester 2-methyl ester 
• 109-06-8 α-picoline 

Relevant articles and documents

Combinations of β3 agonists and growth hormone secretagogues

This invention is directed to pharmaceutical compositions comprising β3adrenergic agonists including (4-(2-(2-(6-aminopyridin-3-yl)-2(R)-hydroxyethylamino)ethoxy)phenyl)acetic acid and growth hormone or growth hormone secretagogues, prodrugs thereof or pharmaceutically acceptable salts of said compounds or said prodrugs. The invention is also directed to methods of using those compositions in the treatment of obesity, diabetes, hypertension and frailty in animals and particularly in humans.

Dipeptide derivatives

This invention is directed to compounds of the Formula and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous growth

Dipeptide derivatives as growth hormone secretagogues

This invention is directed to compounds of the Formula ???and the pharmaceutically-acceptable salts thereof, where the substituents are as defined in the Specification, which are growth hormone secretogogues and which increase the level of endogenous grow